ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,635,885 | +5.7% | 1,828,883 | +19.8% | 0.12% | +13.8% |
Q2 2023 | $46,947,112 | -18.0% | 1,527,232 | -3.9% | 0.11% | -21.6% |
Q1 2023 | $57,246,806 | -3.1% | 1,588,865 | +6.3% | 0.14% | -9.7% |
Q4 2022 | $59,047,978 | -6.0% | 1,494,129 | -4.4% | 0.15% | -12.5% |
Q3 2022 | $62,822,000 | +15.0% | 1,563,519 | +20.3% | 0.18% | +25.7% |
Q2 2022 | $54,646,000 | +698.0% | 1,299,850 | +639.5% | 0.14% | +775.0% |
Q1 2022 | $6,848,000 | -4.8% | 175,779 | -2.6% | 0.02% | +6.7% |
Q4 2021 | $7,191,000 | +81.4% | 180,489 | +64.5% | 0.02% | +66.7% |
Q3 2021 | $3,965,000 | -7.5% | 109,743 | +5.2% | 0.01% | 0.0% |
Q2 2021 | $4,285,000 | -9.6% | 104,277 | -3.2% | 0.01% | -10.0% |
Q1 2021 | $4,739,000 | +16.1% | 107,685 | +32.0% | 0.01% | +25.0% |
Q4 2020 | $4,082,000 | – | 81,557 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
Brown University | 381,759 | $19,107,000 | 13.82% |
Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |